66 related articles for article (PubMed ID: 27162119)
21. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
22. Tumor-infiltrating CD4
Franzoni MS; Brandi A; de Oliveira Matos Prado JK; Elias F; Dalmolin F; de Faria Lainetti P; Prado MCM; Leis-Filho AF; Fonseca-Alves CE
Res Vet Sci; 2019 Oct; 126():29-36. PubMed ID: 31425936
[TBL] [Abstract][Full Text] [Related]
23. Immunostaining for p53 and p16
Munday JS; Ariyarathna H; Aberdein D; Thomson NA
Vet Sci; 2019 Mar; 6(1):. PubMed ID: 30934592
[TBL] [Abstract][Full Text] [Related]
24. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
25. Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
Sledge DG; Webster J; Kiupel M
Vet J; 2016 Sep; 215():43-54. PubMed ID: 27372911
[TBL] [Abstract][Full Text] [Related]
26. Exploring the contrasts: in-depth analysis of human and canine mammary tumors - discoveries at the frontier.
Gherman LM; Tomuleasa D; Cismaru A; Nutu A; Berindan-Neagoe I
Med Pharm Rep; 2024 Apr; 97(2):132-142. PubMed ID: 38746025
[TBL] [Abstract][Full Text] [Related]
27. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies.
Nosalova N; Huniadi M; Horňáková Ľ; Valenčáková A; Horňák S; Nagoos K; Vozar J; Cizkova D
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474142
[TBL] [Abstract][Full Text] [Related]
28. Canine Mammary Cancer: State of the Art and Future Perspectives.
Vazquez E; Lipovka Y; Cervantes-Arias A; Garibay-Escobar A; Haby MM; Queiroga FL; Velazquez C
Animals (Basel); 2023 Oct; 13(19):. PubMed ID: 37835752
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients.
Valdivia G; Alonso-Miguel D; Perez-Alenza MD; Zimmermann ABE; Schaafsma E; Kolling FW; Barreno L; Alonso-Diez A; Beiss V; Affonso de Oliveira JF; Suárez-Redondo M; Fiering S; Steinmetz NF; Vom Berg J; Peña L; Arias-Pulido H
Cells; 2023 Sep; 12(18):. PubMed ID: 37759464
[TBL] [Abstract][Full Text] [Related]
30. The Novel Diagnostic Techniques and Biomarkers of Canine Mammary Tumors.
Kaszak I; Witkowska-Piłaszewicz O; Domrazek K; Jurka P
Vet Sci; 2022 Sep; 9(10):. PubMed ID: 36288138
[TBL] [Abstract][Full Text] [Related]
31. Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.
Sakalauskaitė S; Riškevičienė V; Šengaut J; Juodžiukynienė N
Acta Vet Scand; 2022 Jun; 64(1):14. PubMed ID: 35761297
[TBL] [Abstract][Full Text] [Related]
32. Activity Screening of the Herb
Li Y; Dong M; Wu Z; Huang Y; Qian H; Huang C
Evid Based Complement Alternat Med; 2021; 2021():9939345. PubMed ID: 34257693
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma.
Morello EM; Cino M; Giacobino D; Nicoletti A; Iussich S; Buracco P; Martano M
Animals (Basel); 2021 Jun; 11(6):. PubMed ID: 34199347
[TBL] [Abstract][Full Text] [Related]
34. The role of COX expression in the prognostication of overall survival of canine and feline cancer: A systematic review.
Gregório H; Magalhães TR; Pires I; Prada J; Carvalho MI; Queiroga FL
Vet Med Sci; 2021 Jul; 7(4):1107-1119. PubMed ID: 33751829
[TBL] [Abstract][Full Text] [Related]
35. The Activity Screening of Hmong Herbs
Huang C; Dong M; Luo J; Qian H; Zhang J; Huang Y
Evid Based Complement Alternat Med; 2020; 2020():3585736. PubMed ID: 33163082
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous and Induced Animal Models for Cancer Research.
Onaciu A; Munteanu R; Munteanu VC; Gulei D; Raduly L; Feder RI; Pirlog R; Atanasov AG; Korban SS; Irimie A; Berindan-Neagoe I
Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32878340
[TBL] [Abstract][Full Text] [Related]
37. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
38. 3D chick embryo chorioallantoic membrane model as an in vivo model to study morphological and histopathological features of feline fibrosarcomas.
Zabielska-Koczywąs K; Wojtkowska A; Dolka I; Małek A; Walewska M; Wojtalewicz A; Żbikowski A; Lechowski R
BMC Vet Res; 2017 Jun; 13(1):201. PubMed ID: 28651614
[TBL] [Abstract][Full Text] [Related]
39. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
